Press release | 07 July 2026 MSF calls for inclusion of analogue insulin pens to the Kenyan Social Health Authority benefits package
Statement | 16 June 2026 Europe European Biotech Act Must Deliver Public-Interest Innovation and Equitable Access
Press release | 16 June 2026 Public investment demands public benefits: European Biotech Act must deliver for people
Statement | 18 May 2026 Open-ended Intergovernmental Working Group on the WHO Pandemic Agreement – WHA79/13.3
Statement | 18 May 2026 Follow-up to the political declaration of the high-level meeting of the General Assembly on the prevention and control of non-communicable diseases – WHA79/12.1
Press release | 18 May 2026 Urgent action needed to close devastating vaccination coverage gaps in conflict-affected settings
Press release | 15 May 2026 Countries must lay groundwork to turn Pandemic Agreement commitments into access for all
Press release | 07 July 2026 MSF calls for inclusion of analogue insulin pens to the Kenyan Social Health Authority benefits package
Technical brief | 24 June 2026 The diagnostic blind spot in the 2026 Bundibugyo Ebola disease outbreak: access gaps and priority actions
Statement | 16 June 2026 Europe European Biotech Act Must Deliver Public-Interest Innovation and Equitable Access
Press release | 16 June 2026 Public investment demands public benefits: European Biotech Act must deliver for people
Statement | 18 May 2026 Open-ended Intergovernmental Working Group on the WHO Pandemic Agreement – WHA79/13.3
Statement | 18 May 2026 Follow-up to the political declaration of the high-level meeting of the General Assembly on the prevention and control of non-communicable diseases – WHA79/12.1
Press release | 18 May 2026 Urgent action needed to close devastating vaccination coverage gaps in conflict-affected settings
Press release | 07 July 2026 MSF calls for inclusion of analogue insulin pens to the Kenyan Social Health Authority benefits package
Technical brief | 24 June 2026 The diagnostic blind spot in the 2026 Bundibugyo Ebola disease outbreak: access gaps and priority actions
Statement | 16 June 2026 Europe European Biotech Act Must Deliver Public-Interest Innovation and Equitable Access
Press release | 16 June 2026 Public investment demands public benefits: European Biotech Act must deliver for people
Statement | 18 May 2026 Open-ended Intergovernmental Working Group on the WHO Pandemic Agreement – WHA79/13.3
Statement | 18 May 2026 Follow-up to the political declaration of the high-level meeting of the General Assembly on the prevention and control of non-communicable diseases – WHA79/12.1
Press release | 15 May 2026 Countries must lay groundwork to turn Pandemic Agreement commitments into access for all
Press release | 07 July 2026 MSF calls for inclusion of analogue insulin pens to the Kenyan Social Health Authority benefits package
Technical brief | 24 June 2026 The diagnostic blind spot in the 2026 Bundibugyo Ebola disease outbreak: access gaps and priority actions
Statement | 16 June 2026 Europe European Biotech Act Must Deliver Public-Interest Innovation and Equitable Access
Press release | 16 June 2026 Public investment demands public benefits: European Biotech Act must deliver for people
Statement | 18 May 2026 Open-ended Intergovernmental Working Group on the WHO Pandemic Agreement – WHA79/13.3
Statement | 18 May 2026 Follow-up to the political declaration of the high-level meeting of the General Assembly on the prevention and control of non-communicable diseases – WHA79/12.1
Press release | 18 May 2026 Urgent action needed to close devastating vaccination coverage gaps in conflict-affected settings
Photograph by Diego Baravelli Press release Press release | 11 November 2020 COVID-19 MSF: Governments must demand pharma make all COVID-19 vaccine licensing deals public
Blog Blog | 05 November 2020 COVID-19 Decolonising medicines and global health: We need genuine and lasting reforms that put patients in the driving seat
Photograph by Mariana Abdalla Press release Press release | 03 November 2020 COVID-19 MSF welcomes Fiocruz’s step towards transparency of AstraZeneca deal 2 min
Photograph by Garvit Nangia Press release Press release | 28 October 2020 COVID-19 MSF response to Gavi’s intent to purchase Sanofi-GSK COVID-19 vaccine candidate for the COVAX Facility 3 min
Issue brief Issue brief | 19 October 2020 Tuberculosis DR-TB and TB-Prevention Drugs Under the Microscope, 7th Edition
Statement | 16 October 2020 Intellectual property and trade MSF statement supporting the extension of TRIPS exemption for least-developed countries
Letter | 16 October 2020 COVID-19 United Kingdom Joint UK civil society letter to UK government calling for support for India and South Africa's WTO waiver proposal
